HPV16 E6E7 vaccine (Zhejiang Pukang Biotechnology/Chinese CDCP/Zhejiang AMS)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHPV16 E6E7 vaccine (Zhejiang Pukang Biotechnology/Chinese CDCP/Zhejiang AMS)
Drug Alias NameAd-HPV16E6E7 (Zhejiang Pukang Biotechnology/Chinese CDCP/Zhejiang AMS)Ad-HPV16E6E7
ClassificationVaccines > Application > Therapeutic vaccineVaccines > Development/production technology > Recombinant vector vaccine
Mechanisms of ActionImmunomodulators
TargetsNot applicable
Therapy Area/IndicationsUterine Cervical Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 1 Clinical
Highest Status in ChinaPhase 1 Clinical
Originator CompaniesZhejiang Pukang Biologic Technology Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesZhejiang Academy Of Medical SciencesChinese Center for Disease Control and Prevention (Chinese Academy of Preventive Medicine)Zhejiang Pukang Biologic Technology Co Ltd
Inactive CompaniesN/A
Active IndicationsUterine Cervical Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A